comparemela.com

Latest Breaking News On - Dexcom real time - Page 6 : comparemela.com

Nomura Asset Management Co Ltd Decreases Stock Position in DexCom, Inc (NASDAQ:DXCM)

Nomura Asset Management Co. Ltd. trimmed its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 14.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 181,208 shares of the medical device company’s stock after selling 31,303 shares during the […]

Westfield Capital Management Co LP Grows Stock Position in DexCom, Inc (NASDAQ:DXCM)

Westfield Capital Management Co. LP boosted its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 0.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,857,286 shares of the medical device company’s stock after acquiring an additional 9,421 shares during the […]

1,648 Shares in DexCom, Inc (NASDAQ:DXCM) Acquired by Tidemark LLC

Tidemark LLC bought a new stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 1,648 shares of the medical device company’s stock, valued at approximately $204,000. Several other institutional investors have also added to […]

TCW Group Inc Cuts Position in DexCom, Inc (NASDAQ:DXCM)

TCW Group Inc. decreased its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 10.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 846,662 shares of the medical device company’s stock after selling 99,171 shares during the quarter. DexCom accounts for […]

DexCom (NASDAQ:DXCM) Upgraded at StockNews com

StockNews.com upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research note published on Friday. DXCM has been the subject of several other reports. Canaccord Genuity Group upped their target price on shares of DexCom from $144.00 to $145.00 and gave the stock a buy rating […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.